PATENT CLAIM ANALYSIS

Application Number: 15866669
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["540", "465000"]

Abstract:
The present invention relates to a theranostic system comprising a beacon and a compound selected from the group consisting of a quinazoline-based tyrosine kinase inhibitor and a natural product. The theranostic systems have use in the therapy and diagnosis of tyrosine kinase related malignancies.

Claim (Index 8):
A theranostic system according to any one of  claims 2  to  7 , wherein R 3  represents a hydrogen atom, a halogen atom OR 9 , N(R g )(R h ), SR g  or an optionally substituted alkyl, alkenyl or alkynyl group; wherein R g  and R h  each independently represent a hydrogen atom or an optionally substituted alkyl, acyl, alkenyl or alkynyl group.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 86.0
- Lexical Diversity: 1.39394
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14751795', '10704120', '12209738', '11852604', '11807201']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6471100554416889
- 35 USC 102 Novelty (BERT): 0.6366970184678921
- Combined Prediction Score: 0.6460687517443092
- Mean Citation Score: 314.902338
- Max Citation Score: 570.9696
- Similarity Product: 543.8711333724975

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test